LOS ANGELES — A local pharmaceutical research company, MMRGlobal, plans to offer its antibody technology to universities conducting research on the Ebola virus without charging them royalties for licensing fees.
“In light of the humanitarian crisis from Ebola and other diseases, MMR plans on granting these licenses for research into the development of these and other biotech assets to create treatments for Ebola and other diseases,” said MMR CEO Robert K. Lorsch, in a statement to be released later Tuesday morning. Continue reading “California Pharma Firm to Offer Royalty-Free Licenses for Ebola Research”

Breitbart – by Joel B. Pollak
Breitbart – by Kristin Tate
Breitbart – by Tony Lee
El Paso Times – by Luis Carlos Lopez
USA Today – by Larry Copeland and Doug Stanglin
RT
RT
RT
RT
Mail.com
Mail.com
Mail.com
Mail.com
WKRN 2 News – by Jason Mays
Daily Mail – by Anna Hodgekiss
CNBC
Liberty Unyielding – by Howard Portnoy